Use of sleep aids by young U.S. adults soars: study
By Julie Steenhuysen
CHICAGO (Reuters) - Use of prescription sleep aids nearly tripled among young adults between 1998 and 2006, according to a study released on Thursday by the healthcare business arm of Thomson Reuters.
“Insomnia, a condition traditionally associated with older adults, appears to be causing larger numbers of young adults to turn to prescription sleep aids, and to depend on them for longer periods of time,” said William Marder, senior vice president and general manager for the healthcare business of Thomson Reuters, parent company of Reuters News.
A study of medical and drug claims data found a 50-percent increase in use of the drugs among all adults under 45, who also appear to be using the drugs for a longer period of time to help them fall asleep.
During the study period, the average length of time sleep aids were used by adults under 45 jumped by more than 40 percent — rising to 93 days in 2006 from 64 days in 1998.
But perhaps the most startling finding was the increase in use of sleep aids among college-age adults 18 to 24.
Use in this age group rose to 1,524 users per 100,000 in 2006, up from 599 users per 100,000 in 1998.
“I find it very worrisome that young people who should have a very strong and healthy sleep system are now finding they are turning to medication to help them get to sleep,” Donna Arand, a sleep specialist at Kettering Hospital Sleep Disorder Center in Dayton, Ohio, said in a telephone interview.
Arand said she has seen a number of students seeking sleep aids because their normal sleep patterns have been disrupted in college, and she fears these adults may have trouble adjusting to a normal sleep pattern as their schedules normalize.
RARE SIDE EFFECT
Two-thirds of those in this study population were taking non-benzodiazepine hypnotics — such as Sanofi-Aventis’ Ambien CR and Sepracor Inc’s Lunesta.
These newer sleep aids generally have fewer side effects, but in rare cases they can cause sleep walking.
That may have led to the demise of a 51-year-old Wisconsin man who froze to death while sleep-walking barefoot in his underwear this week in below-zero cold.
The Sawyer County Sheriff’s Office in Hayward, Wisconsin, said Timothy Brueggeman had Ambien at his house, and family members told the Star Tribune newspaper in Minneapolis that he had a history of sleep walking.
Chief Deputy Tim Ziegel said there was no proof that Brueggeman had taken the drug before his death but toxicology tests had been ordered.
“We do not know all the facts about what transpired,” said Sanofi spokeswoman Susan Brook, noting that the circumstances of the man’s death are still being investigated. Continued…
--------------------------------------------------------------------------------------------Related Posts:
By Bappa Majumdar NEW DELHI (Reuters) - HIV/AIDS infections will spread like “bushfire” in parts of India if the country fails to check a spike in the number of intravenous drug users, the United Nations AIDS agency said Thursday. India has the world’s third highest caseload with 2.5 million infections. It has an estimated 200,000 intravenous drug
Full Post: Injecting drugs threaten India’s AIDS fight : U.N.
--------------------------------------------------------------------------------------------
By Lucy Hornby BEIJING (Reuters) - China’s efforts to combat the spread of AIDS among drug users is being undermined by its harsh treatment of drug addicts, Human Rights Watch warned in a report Tuesday. Injecting drugs is one of the main causes of new HIV infections in China, which has helped drive more funding and attention
Full Post: Crackdown on drugs hurts China AIDS fight: report
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Researchers from Harvard School of Public Health in Boston estimate that between 2000 and 2005 more than 330,000 lives were lost because a “feasible and timely” AIDS drug treatment program was not implemented in South Africa. By not implementing a mother-to-child transmission HIV prevention program during the same 5-year period, an
Full Post: Delay in AIDS drug use in South Africa costly
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - The AIDS virus, HIV, may cause blood clots and other problems with blood vessels that can kill patients prematurely even if they are relatively healthy, researchers reported on Monday. They found that patients given breaks from their HIV prescriptions had higher levels of blood proteins associated with inflammation, an often dangerous immune response. The
Full Post: AIDS virus may cause clots
--------------------------------------------------------------------------------------------
By Julie Steenhuysen CHICAGO (Reuters) - Just one extra hour of sleep a day appears to lower the risk of developing calcium deposits in the arteries, a precursor to heart disease, U.S. researchers said on Tuesday. The finding adds to a growing list of health consequences — including weight gain, diabetes, high blood pressure — linked to
Full Post: Skimping on sleep is bad for the heart: U.S. study